The CLOQS Trial - Countdown Lights to Optimize Quality in Stroke
NCT01148602 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3452
Last updated 2015-12-09
Summary
To reduce door-to-needle times in acute stroke treatment. Using an organizational behaviour intervention (a large stopwatch), we will post a visual cue to remind all parties that "time is brain". We hypothesize that this simple visual cue will improve door-to-CT scan times and door-to-needle treatment times, and thus improve treatment response, and reduce adverse events.
Conditions
- Acute Stroke
Interventions
- OTHER
-
LED stopwatch-clock timers
We will attach a large, "in-your-face" red LED stopwatch-clock timers to the patient's stretcher at the moment of ED arrival to act as a constant visual reminder to all team members (physicians, RN's, CT technologists) of the urgency of the situation.
Sponsors & Collaborators
-
University Health Network, Toronto
collaborator OTHER -
Unity Health Toronto
collaborator OTHER -
Sunnybrook Health Sciences Centre
lead OTHER
Principal Investigators
-
Richard Swartz, MD · University of Toronto Stroke Program
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-06-30
- Primary Completion
- 2012-04-30
- Completion
- 2012-04-30
Countries
- Canada
Study Locations
More Related Trials
-
Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke (SENTIS)
NCT00119717 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of CP-101,606 in Subjects With an Acute Stroke
NCT00073476 ·Status: TERMINATED ·Phase: PHASE2
-
Paramedic Initiated Lisinopril For Acute Stroke Treatment
NCT01066572 ·Status: COMPLETED ·Phase: PHASE1
-
STROKE 120 ACTION Trial
NCT07135310 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Thrombolysis of Urokinase for Minor Stroke
NCT04420351 ·Status: COMPLETED ·Phase: PHASE3
-
Mobile Terminal Based Management of Stroke Secondary Prevention Adminstration Effect Research
NCT02618265 ·Status: UNKNOWN ·Phase: NA
-
StroCare - Optimised Cross-sectoral,Coordinated Treatment of Stroke Patients With Patient-orientated Outcome Measurement
NCT04159324 ·Status: COMPLETED ·Phase: NA
-
A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke
NCT05953480 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Clinical Trial of MT200605 for the Treatment of Acute Ischemic Stroke
NCT07205328 ·Status: RECRUITING ·Phase: PHASE2
-
Perfluorocarbon (ABL-101) Oxygenation for Stroke: Trial With GOLD (Glasgow Oxygen Level Dependent Technology) Imaging Theranostic
NCT03463551 ·Status: UNKNOWN ·Phase: PHASE2
-
GD-11 for Injection in the Treatment of Acute Ischemic Stroke
NCT06299579 ·Status: RECRUITING ·Phase: PHASE3
-
The Androtriol Injection for the Treatment of Acute Ischemic Stroke
NCT06679322 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
EFfects of Y-6 SUblingual Tablets foR PaTients With AcUte Ischemic StRokE (FUTURE)
NCT06138834 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Study of a Neuroprotective Drug to Limit the Extent of Damage From an Ischemic Stroke
NCT00630396 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy of Fluoxetine - a Trial in Stroke
NCT02683213 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of the Penumbra™ System in Acute Middle Cerebral Artery (MCA) Stroke
NCT01133223 ·Status: WITHDRAWN ·Phase: PHASE2
-
Efficacy of Semaglutide in Improving Neurological Outcomes After Endovascular Thrombectomy for Acute Ischemic Stroke: A Randomized Double-Blind Controlled Trial
NCT07030621 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Pilot Investigation of Stem Cells in Stroke
NCT01151124 ·Status: COMPLETED ·Phase: PHASE1
-
The Efficacy of Nitric Oxide in Stroke (ENOS) Trial
NCT00989716 ·Status: UNKNOWN ·Phase: PHASE3
-
THrombolysis for Acute Wake-up and Unclear-onset Strokes With Alteplase at 0.6 mg/kg Trial (THAWS)
NCT02002325 ·Status: UNKNOWN ·Phase: PHASE3
-
Thrombolysis With rhPro-UK in 4.5-6 Hours After Acute Ischemic Stroke in a Double-blinded,Controlled Trial
NCT03578822 ·Status: COMPLETED ·Phase: PHASE3
-
Neuroprotection in Acute Ischemic Stroke
NCT03320018 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Prehospital Administration of Normobaric Oxygen in Suspected Stroke
NCT05351073 ·Status: UNKNOWN ·Phase: PHASE2
-
Stroke Card Long-term Follow-Up
NCT04205006 ·Status: UNKNOWN
-
HT-3951 vs. Placebo in Stroke Rehabilitation
NCT02530307 ·Status: TERMINATED ·Phase: PHASE2